Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Product name:
ATLANTISCAN
DIN:
02438380
Product Monograph/Veterinary Labelling:
Date:
2015-06-29
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
NOVA SCOTIA HEALTH AUTHORITY
1276 South Park Street, 1071b Centennial Building Cyclotron Facility
Halifax
Nova Scotia
Canada
B3H 2Y9
Class:
Radiopharmaceutical
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule C
American Hospital Formulary Service (AHFS): See footnote 3
36:00.00 , 78:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V09IX04 FLUDEOXYGLUCOSE (18F)
Active ingredient group (AIG) number:See footnote5
0152591018
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| FLUDEOXYGLUCOSE 18F | 200 MCI / ML |